This inventor holds 39 USPTO granted patents and 15 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Biotheryx, Inc., Signal Pharmaceuticals, Inc., Nippon Kayaku Co., Ltd. Active years: 2002-2026.
Location History:
- San Deigo, CA (US) (2018)
- San Diego, CA (US) (2002 - 2022)
Company Filing History:
25 out of 39 
13 out of 169 
1 out of 27 
Years Active: 2002-2026
Areas of Expertise:
Title: Paul E Erdman: Pioneering Innovator in Pharmaceutical Patents
Introduction
Paul E Erdman is a prominent inventor based in San Diego, CA, renowned for his contributions to the field of pharmaceuticals. With an impressive portfolio of 35 patents, he has played a pivotal role in developing innovative solutions for various medical challenges. His work focuses on creating compounds that address diseases associated with protein malfunction, significantly impacting cancer treatment and other disorders.
Latest Patents
Among his latest inventions are the "Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith." This patent encompasses diaminopyrimidine compounds formulated to offer therapeutic benefits. Additionally, he has developed aminoamide compounds that incorporate amino amide linkers, along with pharmaceutical compositions and medicaments containing these compounds. These innovations are designed to treat or mitigate conditions related to protein malfunction, notably including cancer.
Career Highlights
Throughout his career, Paul has made significant strides in the pharmaceutical industry by working with leading companies such as Biotheryx, Inc. and Signal Pharmaceuticals, Inc. His expertise has contributed to advancing drug development and improving therapeutic outcomes for patients facing serious health challenges.
Collaborations
Paul has also collaborated with notable professionals, including Kyle W H Chan and Leah M Fung. These partnerships have further enhanced the innovation process, bringing diverse perspectives and expertise to the projects they undertook together.
Conclusion
In conclusion, Paul E Erdman's dedication to innovation and his extensive patent portfolio underscore his impact on pharmaceutical research and development. His groundbreaking compounds and commitment to addressing complex medical conditions highlight the importance of inventors in driving advancements that can change lives for the better.